Iron Deficiency Anemia Therapy - Global Strategic Business Report

The global market for Iron Deficiency Anemia Therapy was valued at USD 15.4 Billion in 2024 and is projected to reach USD 23.9 Billion by 2030, growing at a CAGR of 7.6% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Iron Deficiency Anemia Therapy Market - Trends & Future Prospects

Why Is Iron Deficiency Anemia a Global Health Concern?

Iron deficiency anemia (IDA) is one of the most common nutritional deficiencies worldwide, affecting millions of people, particularly women, children, and the elderly. This condition occurs when the body lacks sufficient iron to produce hemoglobin, leading to fatigue, weakness, and other health complications. IDA is particularly prevalent in developing regions, where access to iron-rich foods and healthcare is limited. However, it is also a significant concern in developed countries, where dietary habits, chronic illnesses, and certain medications can contribute to iron deficiency. Addressing IDA is crucial for improving public health outcomes, as untreated anemia can lead to severe complications, including impaired cognitive function, reduced work capacity, and increased risk of maternal and infant mortality.

How Are Advances in Therapy Improving Outcomes for Iron Deficiency Anemia Patients?

Advances in iron deficiency anemia therapy are improving outcomes for patients by offering more effective and convenient treatment options. Traditional oral iron supplements, while widely used, can cause gastrointestinal side effects and are not always effective in restoring iron levels in patients with severe anemia or malabsorption issues. Recent developments in intravenous (IV) iron therapies provide an alternative for these patients, offering rapid replenishment of iron stores with fewer side effects. Additionally, new formulations of oral iron supplements with enhanced absorption and tolerability are becoming available, improving patient compliance and outcomes. The use of combination therapies, such as iron supplements with vitamin C or other enhancers of iron absorption, is also being explored to boost the efficacy of treatments.

What Challenges Are Hindering the Widespread Adoption of Advanced Iron Deficiency Anemia Therapies?

Despite the availability of advanced therapies, several challenges hinder their widespread adoption. One major challenge is the cost and accessibility of IV iron treatments, which can be expensive and require administration in a clinical setting. This limits their use to patients with severe anemia or those who do not respond to oral supplements. Additionally, there is a lack of awareness among patients and healthcare providers about the importance of early diagnosis and treatment of IDA, leading to delays in care. Another challenge is the variability in response to iron therapy, as some patients may not achieve the desired outcomes due to underlying conditions or poor adherence to treatment. Addressing these challenges requires targeted educational initiatives, improved access to affordable treatments, and ongoing research to optimize therapy regimens for different patient populations.

What Factors Are Driving the Growth of the Iron Deficiency Anemia Therapy Market?

The growth of the iron deficiency anemia therapy market is driven by several factors, including the increasing prevalence of anemia, advancements in treatment options, and greater awareness of the condition. The rising incidence of chronic diseases, such as kidney disease and inflammatory bowel disease, which can lead to anemia, is also contributing to the demand for effective therapies. Additionally, the growing focus on maternal and child health, particularly in developing regions, is driving the need for accessible and affordable iron supplements. The expansion of healthcare infrastructure and the availability of new treatment options, such as improved oral and IV iron formulations, are further supporting market growth. As awareness of IDA and its health implications increases, more individuals are seeking diagnosis and treatment, driving demand for a range of therapeutic options.

Report Scope

The report analyzes the Iron Deficiency Anemia Therapy market, presented in terms of market value (USD Thousand). The analysis covers the key segments and geographic regions outlined below.

Segments

Therapy Type (Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion).

Geographic Regions/Countries

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

Market Growth: Understand the significant growth trajectory of the Oral Iron Therapy segment, which is expected to reach $11.1 Billion by 2030 with a CAGR of a 6.9%. The Parenteral Iron Therapy segment is also set to grow at 8.5% CAGR over the analysis period.
Regional Analysis: Gain insights into the U.S. market, valued at $4 Billion in 2024, and China, forecasted to grow at an impressive 11% CAGR to reach $5.8 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Report Features:

Comprehensive Market Data: Independent analysis of annual sales and market forecasts in USD from 2024 to 2030.
In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
Company Profiles: Coverage of major players such as Allergan PLC, AMAG Pharmaceuticals, Inc., Johnson & Johnson, Keryx Biopharmaceuticals, Inc., Luitpold Pharmaceuticals, Inc. and more.
Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Why You Should Buy This Report:

Detailed Market Analysis: Access a thorough analysis of the Global Iron Deficiency Anemia Therapy Market, covering all major geographic regions and market segments.
Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Iron Deficiency Anemia Therapy Market.
Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

How is the Global Iron Deficiency Anemia Therapy Market expected to evolve by 2030?
What are the main drivers and restraints affecting the market?
Which market segments will grow the most over the forecast period?
How will market shares for different regions and segments change by 2030?
Who are the leading players in the market, and what are their prospects?

Some of the 38 major companies featured in this Iron Deficiency Anemia Therapy market report include:

Allergan PLC
AMAG Pharmaceuticals, Inc.
Johnson & Johnson
Keryx Biopharmaceuticals, Inc.
Luitpold Pharmaceuticals, Inc.
Pharmacosmos A/S
Pieris Pharmaceuticals, Inc.

I. METHODOLOGYII. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Influencer Market Insights
World Market Trajectories
Iron Deficiency Anemia Therapy - Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
Global Economic Update

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

Rising Prevalence of Iron Deficiency Anemia Spurs Growth in Therapy Market
Advancements in Oral Iron Supplements Propel Innovation in Anemia Treatment
Growing Demand for Intravenous (IV) Iron Therapies Expands Addressable Market
Shift Towards Non-Invasive Treatment Options Strengthens Business Case for New Therapies
Increased Focus on Early Diagnosis and Screening Drives Adoption of Anemia Therapies
Technological Innovations in Drug Delivery Systems Accelerate Demand for Advanced Therapies
Rising Awareness Campaigns on Iron Deficiency Throws Spotlight on Treatment Options
Expanding Applications of Iron Supplementation in Pregnant Women Generate New Opportunities
Shift Towards Personalized Medicine in Anemia Treatment Drives Market Innovation

4. GLOBAL MARKET PERSPECTIVE

Table 1: World Iron Deficiency Anemia Therapy Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
Table 2: World Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
Table 3: World Historic Review for Iron Deficiency Anemia Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Table 4: World 15-Year Perspective for Iron Deficiency Anemia Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
Table 5: World Recent Past, Current & Future Analysis for Oral Iron Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
Table 6: World Historic Review for Oral Iron Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Table 7: World 15-Year Perspective for Oral Iron Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
Table 8: World Recent Past, Current & Future Analysis for Parenteral Iron Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
Table 9: World Historic Review for Parenteral Iron Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Table 10: World 15-Year Perspective for Parenteral Iron Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
Table 11: World Recent Past, Current & Future Analysis for Red Blood Cell Transfusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
Table 12: World Historic Review for Red Blood Cell Transfusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Table 13: World 15-Year Perspective for Red Blood Cell Transfusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

UNITED STATES

Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
Table 14: USA Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Table 15: USA Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Table 16: USA 15-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2015, 2025 & 2030

CANADA

Table 17: Canada Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Table 18: Canada Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Table 19: Canada 15-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2015, 2025 & 2030

JAPAN

Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
Table 20: Japan Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Table 21: Japan Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Table 22: Japan 15-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2015, 2025 & 2030

CHINA

Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
Table 23: China Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Table 24: China Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Table 25: China 15-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2015, 2025 & 2030

EUROPE

Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
Table 26: Europe Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
Table 27: Europe Historic Review for Iron Deficiency Anemia Therapy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Table 28: Europe 15-Year Perspective for Iron Deficiency Anemia Therapy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
Table 29: Europe Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Table 30: Europe Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Table 31: Europe 15-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2015, 2025 & 2030

FRANCE

Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
Table 32: France Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Table 33: France Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Table 34: France 15-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2015, 2025 & 2030

GERMANY

Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
Table 35: Germany Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Table 36: Germany Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Table 37: Germany 15-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2015, 2025 & 2030

ITALY

Table 38: Italy Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Table 39: Italy Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Table 40: Italy 15-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2015, 2025 & 2030

UNITED KINGDOM

Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
Table 41: UK Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Table 42: UK Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Table 43: UK 15-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2015, 2025 & 2030

SPAIN

Table 44: Spain Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Table 45: Spain Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Table 46: Spain 15-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2015, 2025 & 2030

RUSSIA

Table 47: Russia Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Table 48: Russia Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Table 49: Russia 15-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2015, 2025 & 2030

REST OF EUROPE

Table 50: Rest of Europe Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Table 51: Rest of Europe Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Table 52: Rest of Europe 15-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2015, 2025 & 2030

ASIA-PACIFIC

Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
Table 53: Asia-Pacific Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
Table 54: Asia-Pacific Historic Review for Iron Deficiency Anemia Therapy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Table 55: Asia-Pacific 15-Year Perspective for Iron Deficiency Anemia Therapy by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
Table 56: Asia-Pacific Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
Table 57: Asia-Pacific Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
Table 58: Asia-Pacific 15-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2015, 2025 & 2030

AUSTRALIA

Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)

INDIA

Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)

SOUTH KOREAREST OF ASIA-PACIFIC

LATIN AMERICA

Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)

ARGENTINABRAZILMEXICOREST OF LATIN AMERICA

MIDDLE EAST

Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)

IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST

AFRICA

Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)

IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Allergan PLC
AMAG Pharmaceuticals, Inc.
Johnson & Johnson
Keryx Biopharmaceuticals, Inc.
Luitpold Pharmaceuticals, Inc.
Pharmacosmos A/S
Pieris Pharmaceuticals, Inc.

Table Information

Report Attribute	Details
No. of Pages	192
Published	March 2025
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 15.4 Billion
Forecasted Market Value ( USD ) by 2030	$ 23.9 Billion
Compound Annual Growth Rate	7.6%
Regions Covered	Global

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€4750EUR$4,950USD£3,958GBP
1 - 10 USER LICENSE PDF	The product is a PDF.	This is a 1-10 user license, allowing up to ten users have access to the product.	€9024EUR$9,405USD£7,521GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€14249EUR$14,850USD£11,875GBP

Global Iron Deficiency Anemia Therapy Market - Trends & Future Prospects

Why Is Iron Deficiency Anemia a Global Health Concern?

How Are Advances in Therapy Improving Outcomes for Iron Deficiency Anemia Patients?

What Challenges Are Hindering the Widespread Adoption of Advanced Iron Deficiency Anemia Therapies?

What Factors Are Driving the Growth of the Iron Deficiency Anemia Therapy Market?

Report Scope

Segments

Geographic Regions/Countries

Key Insights:

Report Features:

Why You Should Buy This Report:

Key Questions Answered:

Some of the 38 major companies featured in this Iron Deficiency Anemia Therapy market report include:

Table of Contents

Companies Mentioned (Partial List)

Table Information

Related Topics

Related Reports

Renal Anemia Market

Iron Deficiency Anemia Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

Anemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

Anemia in Chronic Kidney Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

Chemotherapy-Induced Anemia Market Report 2025